Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Breaking News
Supreme Court will take up state bans on gender-affirming care for transgender minors
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Zai Lab Ltd ADR
(NQ:
ZLAB
)
18.66
+0.09 (+0.48%)
Streaming Delayed Price
Updated: 10:34 AM EDT, Jun 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
123,075
Open
18.39
Bid (Size)
18.63 (1)
Ask (Size)
18.66 (2)
Prev. Close
18.57
Today's Range
18.18 - 18.69
52wk Range
13.48 - 32.60
Shares Outstanding
956,637,360
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Zai Lab Announces Dr. Harald Reinhart to Retire as Head of Global Development for Neuroscience, Autoimmune and Infectious Diseases; Dr. Rafael Amado to be Appointed President, Head of Global R&D
June 11, 2024
From
Zai Lab Limited
Via
Business Wire
Why Core & Main Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
June 04, 2024
Via
Benzinga
Performance
YTD
-28.40%
-28.40%
1 Month
+4.13%
+4.13%
3 Month
+14.83%
+14.83%
6 Month
-27.73%
-27.73%
1 Year
-27.65%
-27.65%
More News
Read More
Saia, Annexon, Core Scientific And Other Big Stocks Moving Higher On Tuesday
June 04, 2024
Via
Benzinga
Zai Lab Initiates Global Phase 2 Clinical Trial Evaluating ZL-1102 As a Topical Treatment for Chronic Plaque Psoriasis
May 22, 2024
From
Zai Lab Limited
Via
Business Wire
Zai Lab and Innoviva Specialty Therapeutics Announce NMPA Approval for XACDURO® (Sulbactam-Durlobactam or SUL-DUR) for Hospital-Acquired and Ventilator-Associated Pneumonia Caused by Acinetobacter Baumannii-Calcoaceticus Complex in China
May 20, 2024
From
Zai Lab Limited
Via
Business Wire
Zai Lab Announces Participation in May and June Investor Conferences
May 16, 2024
From
Zai Lab Limited
Via
Business Wire
Zai Lab Announces Acceptance of Supplemental Biologics License Application with Priority Review for Efgartigimod Alfa Injection (Subcutaneous Injection) in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in China
May 14, 2024
From
Zai Lab Limited
Via
Business Wire
Zai Lab Announces Approval of AUGTYRO™ (repotrectinib) for Patients with ROS1-positive NSCLC by China’s NMPA
May 12, 2024
From
Zai Lab Limited
Via
Business Wire
Why Duolingo Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
May 09, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
May 09, 2024
Via
Benzinga
Fight Against Pancreatic Cancer Ramps Up as Market Size Revenues Expected to Exceed $36 Billion by 2036
May 09, 2024
Via
FinancialNewsMedia
Spectrum Brands Posts Upbeat Results, Joins AerSale, Sinclair, ICU Medical And Other Big Stocks Moving Higher On Thursday
May 09, 2024
Via
Benzinga
Top 5 Health Care Stocks That Could Sink Your Portfolio In Q2
May 09, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
May 09, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
May 09, 2024
Via
InvestorPlace
ZLAB Stock Earnings: Zai Lab Beats EPS, Beats Revenue for Q1 2024
May 08, 2024
Via
InvestorPlace
Zai Lab Announces First Quarter 2024 Financial Results and Recent Corporate Updates
May 08, 2024
From
Zai Lab Limited
Via
Business Wire
Zai Lab to Announce First Quarter 2024 Financial Results and Recent Corporate Updates on May 8, 2024
April 15, 2024
From
Zai Lab Limited
Via
Business Wire
Zai Lab Statement on Executive Management Team’s Agreement on Share Activities
April 11, 2024
From
Zai Lab Limited
Via
Business Wire
Week In Review: ProfoundBio, A Seattle-Suzhou ADC Biotech, Acquired By Genmab For $1.8 Billion
April 06, 2024
Via
Talk Markets
Zai Lab Presentations at AACR 2024 Annual Meeting to Showcase Ongoing Clinical Studies in Key Global Oncology Programs
April 02, 2024
From
Zai Lab Limited
Via
Business Wire
One Good, One Bad News For Bristol Myers Squibb's Marketed Drugs: Details
April 01, 2024
Via
Benzinga
Zai Lab Partner Bristol Myers Squibb Announces Pivotal KRYSTAL-12 Confirmatory Trial Evaluating KRAZATI (adagrasib) Meets Primary Endpoint of Progression-Free Survival for Patients with Pretreated KRASG12C-Mutated Locally Advanced or Metastatic...
April 01, 2024
From
Zai Lab Limited
Via
Business Wire
Zai Lab Partner Novocure Announces METIS Phase 3 Clinical Trial Met Primary Endpoint, Demonstrating a Statistically Significant Extension in Time to Intracranial Progression for Patients with Brain Metastases from Non-Small Cell Lung Cancer
March 27, 2024
From
Zai Lab Limited
Via
Business Wire
Shhh! 7 Small-Cap Stocks That Can Double by 2025
March 20, 2024
Via
InvestorPlace
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.